Gastroenterology sets standards for CT colonography

September 07, 2007

Recognizing that CT colonography will play a role in screening for colorectal cancer (CRC), and the critical need to increase overall CRC screening rates, the American Gastroenterological Association (AGA) Institute issued minimum standards for gastroenterologist performance of the test. To ensure competence, a minimum of 75 endoscopically confirmed cases should be interpreted by the physician.

Despite the fact that CT colonography has not yet been endorsed as a primary screening test in asymptomatic, normal risk adults, many patients have shown interest in this test. The indications for CT colonography are controversial, with many payers recommending that this test only be indicated for patients who have had a failed optical colonoscopy or who have a mass obstructing the colon where examination of the entire colon is required prior to surgical resection. Nonetheless, CT colonography may be considered for patients unwilling to undergo other colorectal screening tests, note the authors of the standards paper, which is published in Gastroenterology, the official journal of the AGA Institute.

"Because of our specialized training, gastroenterologists are experts in CRC screening and colorectal disease. It follows that if patients want a 'virtual colonoscopy' it may be highly appropriate to see a qualified gastroenterologist for the test," notes Don Rockey, MD, AGAF, chair of the AGA Institute Task Force on CT Colonography. "As CT colonography technology is evolving, it is important to check that your physician has been properly trained to ensure that the test is performed and interpreted accurately."

After formal training, during which at least 75 tests should be interpreted, the AGA Institute Task Force on CT Colonography, which authored the standards paper, recommends that gastroenterologists should participate in a mentored CT colonography preceptorship with the candidate physically present and involved in the interpretation of at least 25-50 additional cases. In addition, it is expected that those performing CT colonography will undertake ongoing training and self assessment including attending formal continuing medical education-accredited courses in CT colonography.

The AGA Institute Task Force on CT Colonography offers the following recommendations. The full recommendations are available in the September issue of Gastroenterology.

Patient Care Quality Control and SafetyRegulatory Issues Exam and Equipment Specifications Guidelines from multiple agencies and professional societies, including the AGA Institute, underscore the importance of colorectal cancer screening for all individuals 50 years of age and older (younger for certain groups known to be at higher risk). The U.S. Preventive Services Task Force, the U.S. Multi-Specialty Task Force, and others have published recommendations for screening for colorectal cancer, the second-leading cause of cancer deaths in the United States. Currently, recommended screening tests include colonoscopy, flexible sigmoidoscopy, barium enema, and fecal occult blood tests.

The AGA Institute formed the CT Colonography Task Force to develop minimum training standards for gastroenterologists in order to provide guidance, and to ensure minimum training competencies are upheld for the performance of the exam. The AGA Institute continues to monitor CT colonography along with other potential colorectal cancer screening tests, and will continue to develop guidance tools and reports as appropriate. The AGA Institute will host a course on CT colonography for gastroenterologists on March 7-8, 2008, in Washington, DC. Additional information will be available this fall.
-end-
About the AGA Institute

The American Gastroenterological Association (AGA) is dedicated to the mission of advancing the science and practice of gastroenterology. Founded in 1897, the AGA is one of the oldest medical-specialty societies in the United States. Comprised of two non-profit organizations--the AGA and the AGA Institute--our more than 16,000 members include physicians and scientists who research, diagnose and treat disorders of the gastrointestinal tract and liver. The AGA, a 501(c6) organization, administers all membership and public policy activities, while the AGA Institute, a 501(c3) organization, runs the organization's practice, research and educational programs. On a monthly basis, the AGA Institute publishes two highly respected journals, Gastroenterology and Clinical Gastroenterology and Hepatology. The organization's annual meeting is Digestive Disease Week®, which is held each May and is the largest international gathering of physicians, researchers and academics in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery. For more information, please visit www.gastro.org.

About Gastroenterology

Gastroenterology, the official journal of the AGA Institute, is the most prominent scientific journal in the specialty and is in the top one percent of indexed medical journals internationally. The journal publishes clinical and basic science studies of all aspects of the digestive system, including the liver and pancreas, as well as nutrition. The journal is abstracted and indexed in Biological Abstracts, CABS, Chemical Abstracts, Current Contents, Excerpta Medica, Index Medicus, Nutrition Abstracts and Science Citation Index. For more information, visit www.gastrojournal.org.

American Gastroenterological Association

Related Colorectal Cancer Articles from Brightsurf:

Colorectal cancer treatment: the winning combinations
Chemotherapy has distressing side effects for patients and increases the risk of developing resistance to the treatment.

A new model to predict survival in colorectal cancer
This signature could be useful in clinical practice, especially for colorectal cancer diagnosis and therapy.

Roadmap to reducing colorectal cancer deaths
The American Gastroenterological Association has outlined a strategy to increase the number of people screened via tests that are more convenient, accurate and less expensive and tailored to people's individual cancer risks.

Study provides new insight on colorectal cancer growth
A new study by researchers at the University of Kentucky identifies a novel function of the enzyme spermine synthase to facilitate colorectal cancer growth.

Researchers ID target for colorectal cancer immunotherapy
Researchers at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center have identified a target for colorectal cancer immunotherapy.

Colorectal cancer partner-in-crime identified
A protein that helps colorectal cancer cells spread to other parts of the body could be an effective treatment target.

Cancer cell reversion may offer a new approach to colorectal cancer treatment
A novel approach to reverse the progression of healthy cells to malignant ones may offer a more effective way to eradicate colorectal cancer cells with far fewer side effects, according to a KAIST research team based in South Korea.

A novel pathway to target colorectal cancer
Survival rates for patients with late-stage colorectal cancer are dismal, and new therapeutic strategies are needed to improve outcomes.

Colorectal cancer rates in Canada
The incidence of colorectal cancer among younger adults increased in recent years in this analysis of data from Canadian national cancer registries that included about 688,000 new colorectal cancers diagnosed over more than 40 years.

Cancer drugs promote stem cell properties of colorectal cancer
Scientists from the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) and the Mannheim University Medical Center have now discovered that a certain group of cancer drugs (MEK Inhibitors) activates the cancer-promoting Wnt signalling pathway in colorectal cancer cells.

Read More: Colorectal Cancer News and Colorectal Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.